Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ IFI35 Polyclonal Antibody
Rabbit Polyclonal Antibody
$237.00 - $539.50
Specifications
Antigen | IFI35 |
---|---|
Concentration | 0.5 mg/mL |
Content And Storage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
Applications | Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
Classification | Polyclonal |
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
PIPA5119218
|
Invitrogen™
PA5119218 |
200 μL |
Each for $539.50
|
|
|||||
PIPA5121833
|
Invitrogen™
PA5121833 |
20 μL |
Each for $237.00
|
|
|||||
Description
IFI35 Polyclonal Antibody for Western Blot, ICC/IF, IHC (P)
Interferon-Induced Protein 35 (IFI35), encoded by the IFI35 gene, is located on chromosome 17 and is recognized for its role in immune response modulation, especially under viral stress conditions. Structurally, IFI35 is part of a complex regulatory network that influences non-canonical NF-kB signaling. This process involves the proteasomal processing of p105 into the DNA-binding transcription factor p50, which forms a heterodimer with RELB (RELB/p50) to activate cell chemotaxis autonomously. The gene's dynamic expression under viral stress has been linked to various immune regulatory networks and is crucial for immune cell recruitment and maintenance, particularly M2-like tumor-associated macrophages (TAMs) within the tumor microenvironment. IFI35 upregulation is significant in conditions of neuroinflammation and multiple sclerosis, especially in patients treated with interferons (IFN), indicating its potential as a biomolecular marker. Additionally, IFI35's role in triple-negative breast cancer highlights its impact on antitumor immunity, where its ablation enhances the infiltration of effector CD8+ T cells and sensitizes tumors to anti-PD-1 immunotherapy. This positions IFI35 as a key player in both immune response and cancer treatment strategies.Specifications
IFI35 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Polyclonal | |
Liquid | |
IgG | |
Human, Pig | |
IFI35 | |
2010008K16Rik; AW986054; IFI35; ifi-35; IFP 35; IFP35; interferon induced protein 35; interferon-induced 35 kDa protein; Interferon-induced 35 kDa protein homolog; interferon-induced protein 35 | |
IFI35 | |
Primary | |
Antigen affinity chromatography, Protein A |
0.5 mg/mL | |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
Unconjugated | |
Rabbit | |
RUO | |
PBS with 50% glycerol and 0.05% ProClin 300; pH 7.4 | |
P80217 | |
100624758, 3430 | |
Recombinant protein Interferon Inducible Protein 35. The antigen corresponds to amino acid range 2-286 of the target protein. | |
Antibody |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title